Chatham Lodging Trust (CLDT) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
27 Feb, 2026Executive summary
Achieved industry-leading operating margins in 2025, reclaiming the top spot for the first time since the pandemic, and returned to profitability with $2.6 million net income to common shareholders in Q4 2025, reversing a $3.7 million loss in Q4 2024.
Outperformed industry RevPAR for the fourth consecutive year, despite flat overall RevPAR.
Sold four older, lower RevPAR hotels for $71–$71.4 million and repurchased 1.8 million shares, returning $35 million to shareholders through dividends and buybacks.
Reduced net debt by $70 million and leverage ratio to 20%, down from 35% in 2019 and 23% year-over-year.
Completed $500 million in new financing at lower borrowing costs, increasing liquidity.
Financial highlights
Q4 2025 hotel EBITDA was $22.4 million; adjusted EBITDA $20.2 million; adjusted FFO $0.21 per share, up 5% year-over-year.
GOP margin for Q4 was 40–40.2%, hotel EBITDA margin 33–33.2%; GOP margin declined only 30–100 bps despite 1.8% RevPAR drop.
Hotel EBITDA margins increased 70 bps due to $550,000 in property tax refunds.
For 2025, RevPAR increased 4.4% in Q1, then declined 0.4% in Q2, 0.9% in Q3, and 1.8% in Q4 to $131.
Labor and benefits costs increased just 1.2% per occupied room in Q4; headcount down 13% year-over-year.
Outlook and guidance
2026 guidance: RevPAR $142–$145 (-0.5% to +1.5%), adjusted EBITDA $84–$89 million, adjusted FFO per share $1.04–$1.14, and hotel EBITDA margin 33.5–34.5%.
2026 net loss to common shares projected at $(13.0)–$(8.0) million.
Q1 2026 RevPAR expected to decline low single digits, then turn positive for the rest of the year.
Guidance assumes SOFR rate cuts, declining interest expense, and no additional acquisitions or dispositions.
Latest events from Chatham Lodging Trust
- Industry-leading margins and RevPAR, strong balance sheet, and upside from tech market recovery.CLDT
Investor presentation2 Mar 2026 - Q2 RevPAR up 4%, Phoenix hotel acquired, and balance sheet strengthened despite higher costs.CLDT
Q2 20242 Feb 2026 - Q3 RevPAR growth, asset sales, and tech market strength support debt reduction and outperformance.CLDT
Q3 202416 Jan 2026 - Q4 RevPAR up 4%, margins expand, and leverage falls as tech markets drive growth.CLDT
Q4 202423 Dec 2025 - Proxy covers trustee elections, auditor ratification, executive pay, and equity plan amendment.CLDT
Proxy Filing2 Dec 2025 - Shareholders will vote on directors, auditor ratification, compensation, and plan amendment.CLDT
Proxy Filing2 Dec 2025 - Board urges approval of Equity Incentive Plan amendment to sustain aligned, cost-effective pay.CLDT
Proxy Filing2 Dec 2025 - Outperforming peers in RevPAR and margins, with strong growth potential from business travel recovery.CLDT
Investor Presentation27 Nov 2025 - Q2 2025 delivered resilient RevPAR, reduced leverage, and robust share repurchases.CLDT
Q2 202523 Nov 2025